Lessons learned from developing and scaling up implementation of programs for advanced HIV disease
Chair
Appolinaire TIAM, Elizabeth Glaser Pediatric AIDS Foundation, United States
Organizer
Share
Despite tremendous progress in the global fight against HIV/AIDS evidenced by declining HIV incidence and expanded access to antiretroviral therapy, decline in AIDS-related deaths have plateaued. Up to half of PLHIV present to care with Advanced HIV disease (AHD). Individuals with AHD are at a higher risk of death even after starting ART, and are prone to opportunistic infections including TB, severe bacterial infections, malnutrition and cryptococcal meningitis. In 2021, there were an estimated 650,000 HIV-related deaths globally, including 95,000 children. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) supports governments in implementing AHD programs in 11 countries in Sub-Saharan Africa (SSA). SSA alone bears an estimated 60% of these deaths. With funding from PEPFAR, CDC, USAID and the Gates Foundation, EGPAF intends to highlight the programmatic lessons learned, and the real-world evidence generated from AHD program implementation in Malawi, Cote d’Ivoire and Lesotho.
07:30
5 min
Opening remarks
Elizabeth Glaser Pediatric AIDS Foundation, United States
07:35
15 min
Overview of EGPAF's work on AHD
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION, Kenya
07:50
20 min
Dissemination of study results - Malawi
Elizabeth Glaser Pediatric AIDS Foundation, Malawi
Elizabeth Glaser Pediatric Aids FOundation, Malawi
08:10
45 min
Panel Discussion & Q&A
Elizabeth Glaser Pediatric AIDS Foundation, United States
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION, Kenya
Elizabeth Glaser Pediatric AIDS Foundation, Malawi
Elizabeth Glaser Pediatric Aids FOundation, Malawi
Elizabeth Glaser Pediatric AIDS Foundation, United States
08:55
5 min
Concluding remarks
Elizabeth Glaser Pediatric AIDS Foundation, United States